XOROX (Agepha Pharma Pty Ltd)
Product name
XOROX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
172 working days (255)
Active ingredients
aciclovir
Registration type
New generic medicine
Indication
XOROX (eye ointment) is indicated for the treatment of herpes Simplex keratitis.
Registration process
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.